Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
17
|
pubmed:dateCreated |
1989-7-13
|
pubmed:abstractText |
Expression of the proto-oncogene p93c-fes and its associated tyrosine kinase activity is marked in mature granulocytes, monocytes, differentiated HL-60 leukemia cells, and leukemia cell lines KG-1, THP-1, HEL, and U-937, which can be induced to differentiate along the granulocyte/monocyte pathway. Conversely, p93-c-fes expression is absent in the K562 cell line, which is resistant to myeloid differentiation. Upon transfection and clonal selection of K562 cells using a mammalian expression vector containing the 13-kilobase pair c-fes gene, c-fes mRNA was transcribed and p93-c-fes tyrosine activity kinase was expressed. Clones expressing c-fes underwent myeloid differentiation as assessed by the appearance of phagocytic activity, Fc receptors, nitro blue tetrazolium reduction, Mac-1 immunofluorescence, and lysozyme production. These results indicate that the expression of the c-fes protooncogene and its associated tyrosine kinase activity plays a major role in the initiation of myeloid differentiation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/FES protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Protein-Tyrosine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-fes
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
264
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
10276-81
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:2656706-Animals,
pubmed-meshheading:2656706-Cell Differentiation,
pubmed-meshheading:2656706-Cell Division,
pubmed-meshheading:2656706-Cell Line,
pubmed-meshheading:2656706-Genetic Vectors,
pubmed-meshheading:2656706-Humans,
pubmed-meshheading:2656706-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:2656706-Phenotype,
pubmed-meshheading:2656706-Protein-Tyrosine Kinases,
pubmed-meshheading:2656706-Proto-Oncogene Proteins,
pubmed-meshheading:2656706-Proto-Oncogene Proteins c-fes,
pubmed-meshheading:2656706-Proto-Oncogenes,
pubmed-meshheading:2656706-Transfection
|
pubmed:year |
1989
|
pubmed:articleTitle |
K562 leukemia cells transfected with the human c-fes gene acquire the ability to undergo myeloid differentiation.
|
pubmed:affiliation |
Laboratory of Biological Chemistry, Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland 20892.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|